Get the Stockscreener App
1.07
5.31%
-0.06
After Hours:
1.10
0.03
+2.80%
AEON Biopharma Inc. Stock (AEON) Forecast
The AEON Biopharma Inc. (AEON) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.4668, representing a +130.54% increase from the current price of $1.07. The highest analyst price target is $3.7636, and the lowest is $1.17.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AEON Price Target
Average 7.1623
(+569.37% Upside)
Is AEON Biopharma Inc. (AEON) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.46 | Sell |
| STOCH(9,6) | 86.42 | Sell |
| STOCHRSI(14) | 66.82 | Neutral |
| MACD(12,26) | 0.071 | Buy |
| ADX(14) | 29.99 | Buy |
| William %R | -28.42 | Neutral |
| CCI(14) | 188.17 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9169
Buy
|
0.9528
Buy
|
| MA20 |
0.8502
Buy
|
0.8856
Buy
|
| MA50 |
0.7865
Buy
|
0.8498
Buy
|
| MA100 |
0.7716
Buy
|
2.287
Sell
|
| MA200 |
3.8166
Sell
|
14.75
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, AEON could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on AEON, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.46 indicates that AEON is overbought. This suggests that AEON price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 86.42 indicates that AEON is oversold. This means that AEON price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.82 indicates that AEON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.99 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 188.17 indicates that AEON is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term AEON price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about AEON Biopharma Inc. financial reports and earnings history, AEON Biopharma Inc. (AEON) stock could reach $2.5676 by 2030, $16.50 by 2040 and $28.07 by 2050. See the projected annual prices until 2050 of the AEON Biopharma Inc. stock below:
- AEON Biopharma Inc. (AEON) is expected to reach an average price of $13.23 in 2035, with a high prediction of $12.54 and a low estimate of $8.3762. This indicates an $1,136% rise from the last recorded price of $1.07.
- AEON Biopharma Inc. (AEON) stock is projected to chart a bullish course in 2040, with an average price target of $14.87, representing an $1,290% surge from its current level. The forecast ranges from a conservative $15.31 to a sky-high $16.50.
- Our analysts predict AEON Biopharma Inc. (AEON) to jump 2,489% by 2045, soaring from $20.92 to an average price of $27.70, potentially reaching $28.14. While $20.92 is the low estimate, the potential upside is significant.
- AEON Biopharma Inc. (AEON) stock is expected to climb by 2050, reaching an average of $26.46, a $2,373% jump from its current level. However, a wide range of estimates exists, with high and low targets of $28.07 and $27.31, respectively, highlighting the market's uncertainty.
AEON Biopharma Inc. Stock (AEON) Year by Year Forecast
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2025
AEON Biopharma Inc. Stock (AEON) is expected to reach an average price of $8.2115 in 2025, with a high prediction of $15.25 and a low estimate of $1.17. This indicates an +667.43% rise from the last recorded price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2025 | $2.1126 | $1.17 | $3.7636 | +97.44% |
| December, 2025 | $2.2858 | $1.8406 | $3.4279 | +113.63% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2026
The predicted value for AEON Biopharma Inc. (AEON) in 2026 is set at an average of $7.1511. Estimates vary from a peak of $14.29 to a trough of $0.00774, indicating an +568.33% surge from the present price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8064 | $0.7664 | $2.5785 | -24.63% |
| February, 2026 | $2.767 | $0.5025 | $2.777 | +158.60% |
| March, 2026 | $4.0075 | $1.8251 | $5.2875 | +274.54% |
| April, 2026 | $4.1308 | $3.5028 | $5.6608 | +286.05% |
| May, 2026 | $8.4113 | $3.7534 | $8.5613 | +686.10% |
| June, 2026 | $12.85 | $8.1405 | $12.94 | +1,101% |
| July, 2026 | $1.8751 | $1.8351 | $14.29 | +75.24% |
| August, 2026 | $0.03 | $0.03 | $2.8504 | -97.20% |
| September, 2026 | $1.5009 | $0.1602 | $2.2506 | +40.28% |
| October, 2026 | $0.2517 | $0.0815 | $1.9361 | -76.48% |
| November, 2026 | $1.2825 | $0.00774 | $1.5525 | +19.86% |
| December, 2026 | $2.9434 | $0.7458 | $4.2234 | +175.08% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for AEON Biopharma Inc. (AEON) is $6.6724, with a high forecast of $13.34 and a low forecast of $0.00868. This indicates an +523.58% increase from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.5542 | $2.4538 | $4.6042 | +325.62% |
| February, 2027 | $5.8749 | $2.6243 | $6.1349 | +449.06% |
| March, 2027 | $11.89 | $5.6751 | $11.98 | +1,011% |
| April, 2027 | $3.8566 | $2.5544 | $13.34 | +260.43% |
| May, 2027 | $2.037 | $0.0872 | $3.9868 | +90.37% |
| June, 2027 | $0.8109 | $0.4568 | $1.0732 | -24.21% |
| July, 2027 | $0.4181 | $0.00868 | $0.9637 | -60.92% |
| August, 2027 | $0.4072 | $0.8804 | $0.7126 | -61.95% |
| September, 2027 | $0.3915 | $0.0285 | $1.475 | -63.41% |
| October, 2027 | $2.6825 | $0.1918 | $3.1592 | +150.70% |
| November, 2027 | $3.9434 | $1.5979 | $4.8134 | +268.54% |
| December, 2027 | $6.3921 | $3.0511 | $8.8521 | +497.39% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2028
In 2028, AEON Biopharma Inc. (AEON) is projected to reach an average price of $6.1995, with a high projection of $12.38 and a low estimate of $0.0215. This indicates an +479.40% rise from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.683 | $1.611 | $12.38 | +244.21% |
| February, 2028 | $0.716 | $0.0215 | $3.9208 | -33.08% |
| March, 2028 | $1.4642 | $1.0783 | $1.74 | +36.84% |
| April, 2028 | $2.173 | $1.1536 | $0.863 | +103.09% |
| May, 2028 | $1.5166 | $2.0125 | $1.8372 | +41.74% |
| June, 2028 | $0.6255 | $0.7508 | $0.6513 | -41.54% |
| July, 2028 | $0.8657 | $0.3557 | $2.0951 | -19.10% |
| August, 2028 | $2.9321 | $0.5715 | $3.8021 | +174.03% |
| September, 2028 | $6.9632 | $2.0474 | $6.9879 | +550.77% |
| October, 2028 | $5.8943 | $4.7791 | $11.42 | +450.87% |
| November, 2028 | $1.6292 | $0.6676 | $3.0396 | +52.27% |
| December, 2028 | $2.1543 | $1.984 | $2.94 | +101.34% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2029
The 2029 price forecast for AEON Biopharma Inc. Stock (AEON) is $5.3199 on average, with a high prediction of $10.46 and a low estimate of $0.1792. This represents an +397.19% increase from the previous price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.3202 | $2.3158 | $2.0102 | +210.30% |
| February, 2029 | $3.3889 | $3.1445 | $2.9617 | +216.72% |
| March, 2029 | $1.5675 | $1.8375 | $2.616 | +46.50% |
| April, 2029 | $0.3562 | $0.5168 | $1.4959 | -66.71% |
| May, 2029 | $0.0679 | $0.3221 | $1.5551 | -93.65% |
| June, 2029 | $4.9792 | $0.1792 | $5.9992 | +365.35% |
| July, 2029 | $4.7306 | $3.8206 | $10.46 | +342.11% |
| August, 2029 | $1.3753 | $0.2758 | $6.2734 | +28.53% |
| September, 2029 | $3.8496 | $2.6525 | $4.14 | +259.78% |
| October, 2029 | $3.4877 | $3.4781 | $2.6827 | +225.96% |
| November, 2029 | $4.8162 | $4.2766 | $4.0862 | +350.11% |
| December, 2029 | $2.7047 | $3.0747 | $3.8858 | +152.78% |
AEON Biopharma Inc. Stock (AEON) Price Forecast for 2030
AEON Biopharma Inc. Stock (AEON) is expected to reach an average price of $4.7626 in 2030, with a high forecast of $9.5021 and a low forecast of $0.0232. This signifies an +345.11% surge from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4128 | $1.5734 | $2.5676 | +32.04% |
| February, 2030 | $1.0013 | $0.4317 | $0.7575 | -6.42% |
| March, 2030 | $3.4302 | $0.0398 | $3.5802 | +220.58% |
| April, 2030 | $8.0217 | $3.3103 | $8.1117 | +649.69% |
| May, 2030 | $2.7664 | $0.0232 | $9.5021 | +158.54% |
| June, 2030 | $6.03 | $3.5657 | $5.34 | +463.55% |
| July, 2030 | $4.3104 | $4.6404 | $3.9121 | +302.84% |
| August, 2030 | $5.4087 | $4.6425 | $4.9766 | +405.48% |
| September, 2030 | $4.227 | $4.917 | $5.2108 | +295.04% |
| October, 2030 | $2.3774 | $4.0111 | $3.7891 | +122.18% |
| November, 2030 | $0.6157 | $1.4657 | $1.8065 | -42.46% |
| December, 2030 | $0.856 | $0.964 | $1.9534 | -20.00% |
1.11%
Cap:
|
Volume (24h):